polymyositis pm type chronic inflammation muscles inflammatory myopathy related dermatomyositis inclusion body myositis name means inflammation many muscles poly myos itis inflammation polymyositis mainly found endomysial layer skeletal muscle whereas dermatomyositis characterized primarily inflammation perimysial layer skeletal hallmark polymyositis weakness andor loss muscle mass proximal musculature well flexion neck symptoms associated marked pain areas well hip extensors often severely affected leading particular difficulty climbing stairs rising seated position skin involvement dermatomyositis absent polymyositis dysphagia difficulty swallowing problems esophageal motility occur many patients low grade fever enlarged lymph nodes may present foot drop one feet symptom advanced polymyositis inclusion body myositis systemic involvement polymyositis includes interstitial lung disease ild heart disease heart failure conduction polymyositis tends become evident adulthood presenting bilateral proximal muscle weakness often noted upper legs due early fatigue walking sometimes weakness presents inability rise seated position without help inability raise ones arms ones head weakness generally progressive accompanied lymphocytic inflammation mainly cytotoxic cellscitation needed polymyositis associated inflammatory myopathies associated increased risk features found associated increased risk cancer older age age greater male sex difficulty swallowing death skin cells cutaneous vasculitis rapid onset myositis weeks elevated creatine kinase higher erythrocyte sedimentation rate higher creactive protein levels several factors associated lowerthanaverage risk including presence interstitial lung disease joint inflammationjoint pain raynauds syndrome malignancies associated nasopharyngeal cancer lung cancer nonhodgkins lymphoma bladder cancer amongst cardiac involvement manifests typically heart failure present interstitial lung disease found patients polymyositis defined hrct restrictive ventilatory defects compatible interstitial lung polymyositis inflammatory myopathy mediated cytotoxic cells yet unknown autoantigen dermatomyositis humorally mediated angiopathy resulting myositis typical cause polymyositis unknown may involve viruses autoimmune factors cancer may trigger polymyositis dermatomyositis possibly immune reaction cancer also attacks component tentative evidence association celiac diagnosis fourfold history physical examination elevation creatine kinase electromyograph emg alteration positive muscle hallmark clinical feature polymyositis proximal muscle weakness less important findings muscle pain dysphagia cardiac pulmonary findings present approximately cases patients polymyositiscitation needed sporadic inclusion body myositis sibm often misdiagnosed polymyositis dermatomyositis differentiated myositis respond treatment likely ibm sibm comes months years polymyositis comes weeks months polymyositis tends respond well treatment least initially ibm notcitation needed first line treatment polymyositis corticosteroids specialized exercise therapy may supplement treatment enhance quality polymyositis affects females greater frequency discovery several myositisspecific autoantibodies past decades enabled description discrete subsets diagnosis specifically discovery antisynthetase syndrome reducing number diagnoses httpsenwikipediaorgwikipolymyositis